REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,460 | -17.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $19,990 | +5.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $18,910 | +82117.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $23 | -99.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $26,000 | +4.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $25,000 | -24.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $33,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $33,000 | -21.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $42,000 | +7.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | +14.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $34,000 | -24.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $45,000 | +60.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $28,000 | -24.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $37,000 | +15.6% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $32,000 | -22.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $41,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |